|Articles|March 17, 2003
HSE P&T Portfolio: Humira
Adalimumab(Humira)for use in adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more disease-modifying antirheumatic drugs.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Q&A: Fentanyl, Opiophobia Concurrently Contribute to Ongoing Opioid Crisis
2
Expansion of OTC Contraceptive Could Fill Reproductive Health Disparities
3
Finerenone Shows Benefits for Chronic Kidney Disease for Patients With Type 1 Diabetes
4
Pharmacists’ Expanding Roles in Diabetes, Community Health Care
5
















































































































































